Target Name: PRICKLE1
NCBI ID: G144165
Review Report on PRICKLE1 Target / Biomarker Content of Review Report on PRICKLE1 Target / Biomarker
PRICKLE1
Other Name(s): prickle planar cell polarity protein 1 | FLJ31627 | Prickle planar cell polarity protein 1, transcript variant 1 | prickle homolog 1 | EPM1B | MGC138902 | MGC138903 | Prickle-like protein 1 | REST/NRSF-interacting LIM domain protein 1 | PRIC1_HUMAN | REST/NRSF interacting LIM domain protein | VELP2 | REST (RE-1 silencing transcription factor)/NRSF (neuron-restrictive silencer factor)-interacting LIM domain protein | RILP | PRICKLE1 variant 1 | PRICKLE1 variant 2 | FLJ31937 | Prickle planar cell polarity protein 1, transcript variant 2 | prickle-like 1

PRICKLE1: A Potential Drug Target and Biomarker for Cellular Communication

Introduction

Intercellular communication is a key process for maintaining normal function and biological diversity of tissues and organs. Impaired cell-to-cell communication can lead to a variety of diseases, including cancer, neurodegenerative diseases, immune disorders, etc. Therefore, studying the molecular mechanisms of intercellular communication and developing new drug targets are of great clinical significance. PRICKLE1 is a protein expressed in neurons and is thought to play an important role in intercellular communication. This article will introduce the role of PRICKLE1, its intercellular communication mechanism, and its potential as a drug target.

The role of PRICKLE1

PRICKLE1 is a glycoprotein that is highly expressed on neuronal cell membranes. The main function of PRICKLE1 is to participate in intercellular communication, especially in synaptic transmission between neurons. PRICKLE1 can bind to proteins on the cell membrane or other intracellular molecules, thereby promoting intercellular communication.

PRICKLE1 plays an important role in synaptic transmission between neurons. Synaptic transmission between neurons is achieved by neurotransmitters transmitting signals in the synaptic cleft. The role of PRICKLE1 in this process is to enhance communication between neurons by binding to neurotransmitter receptors and promoting the binding of neurotransmitters to receptors. In addition, PRICKLE1 can also affect communication between neurons by regulating potential changes on neuronal cell membranes.

Intercellular communication mechanism of PRICKLE1

PRICKLE1's intercellular communication mechanism is achieved by binding to proteins or other intracellular molecules on the cell membrane. These proteins or other molecules are called ligands, and they bind to glycosylation sites on PRICKLE1. When a ligand binds to the glycosylation site on PRICKLE1, it changes the conformation of PRICKLE1, resulting in a series of physical and chemical changes. These changes can affect the activity of PRICKLE1, thereby affecting communication between neurons.

Drug target potential of PRICKLE1

Because PRICKLE1 plays an important role in intercellular communication, it is considered a potential drug target. Currently, researchers are exploring the role of PRICKLE1 in treating neurodegenerative diseases, neuropsychological disorders and other diseases.

The role of PRICKLE1 in neurodegenerative diseases

Neurodegenerative diseases, such as Parkinson's disease, Alzheimer's disease, and Huntington's disease, are all related to impaired synaptic transmission between neurons. These diseases lead to neuronal death, damage to neuronal connections, and accumulation of abnormal signals within the neuronal cytoplasm. Therefore, the role of PRICKLE1 in these diseases has attracted the attention of researchers.

The role of PRICKLE1 in neuropsychological diseases

Neuropsychological diseases, such as depression, anxiety, and obsessive-compulsive disorder, are also related to synaptic transmission between neurons. These diseases cause excessive neuronal activity or excessive inhibition, which affects communication between neurons. Therefore, the role of PRICKLE1 in these diseases has also attracted the attention of researchers.

Clinical applications of PRICKLE1

Currently, PRICKLE1 is being widely studied as a drug target. Researchers are exploring PRICKLE1's role in treating neurodegenerative diseases, neuropsychological disorders and other conditions. By inhibiting the activity of PRICKLE1, the above diseases can be treated. In addition, researchers are also exploring the use of PRICKLE1 as a biomarker for communication between neurons to help diagnose these diseases.

in conclusion

PRICKLE1 is a glycoprotein that is highly expressed on neuronal cell membranes. The main function of PRICKLE1 is to participate in intercellular communication, especially in synaptic transmission between neurons. PRICKLE1 plays an important role in synaptic transmission between neurons and is therefore considered a potential drug target. In addition, PRICKLE1 also plays an important role in neuropsychological diseases and therefore can serve as a biomarker for communication between neurons. In the future, studying the mechanism of PRICKLE1 to develop new drug targets and evaluating the role of PRICKLE1 in the treatment of neurodegenerative diseases, neuropsychological diseases and other diseases will bring more hope to the clinic.

Protein Name: Prickle Planar Cell Polarity Protein 1

Functions: Involved in the planar cell polarity pathway that controls convergent extension during gastrulation and neural tube closure. Convergent extension is a complex morphogenetic process during which cells elongate, move mediolaterally, and intercalate between neighboring cells, leading to convergence toward the mediolateral axis and extension along the anteroposterior axis. Necessary for nuclear localization of REST. May serve as nuclear receptor

The "PRICKLE1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRICKLE1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

PRICKLE2 | PRICKLE2-AS1 | PRICKLE2-AS2 | PRICKLE3 | PRICKLE4 | PRIM1 | PRIM2 | PRIM2BP | PRIMA1 | PRIMPOL | PRINS | PRKAA1 | PRKAA2 | PRKAB1 | PRKAB2 | PRKACA | PRKACB | PRKACG | PRKAG1 | PRKAG2 | PRKAG2-AS1 | PRKAG2-AS2 | PRKAG3 | PRKAR1A | PRKAR1B | PRKAR2A | PRKAR2A-AS1 | PRKAR2B | PRKCA | PRKCA-AS1 | PRKCB | PRKCD | PRKCE | PRKCG | PRKCH | PRKCI | PRKCQ | PRKCQ-AS1 | PRKCSH | PRKCZ | PRKCZ-AS1 | PRKD1 | PRKD2 | PRKD3 | PRKDC | PRKG1 | PRKG1-AS1 | PRKG2 | PRKG2-AS1 | PRKN | PRKRA | PRKRIP1 | PRKX | PRKXP1 | PRKY | PRL | PRLH | PRLHR | PRLR | PRM1 | PRM2 | PRM3 | PRMT1 | PRMT2 | PRMT3 | PRMT5 | PRMT5-DT | PRMT6 | PRMT7 | PRMT8 | PRMT9 | PRNCR1 | PRND | PRNP | PRNT | Pro-Neuregulin | PROB1 | PROC | PROCA1 | PROCR | PRODH | PRODHLP | Prohibitin | PROK1 | PROK2 | Prokineticin Receptor (PK-R) | PROKR1 | PROKR2 | Prolactin receptor (isoform 1) | Prolyl 4-hydroxylase | PROM1 | PROM2 | PROP1 | Propionyl-CoA Carboxylase | PRORP | PRORSD1P | PRORY | PROS1 | PROS2P | PROSER1